Safety and Efficacy Evaluation of Decitabine With R-GDP
Clinical trial NCT03535753 · UNKNOWN
Trial details
- NCT number
- NCT03535753
- Sponsor
- Beijing Immunochina Medical Science & Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2020-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.